Skip to content

Education for Prevention of Melanoma in Hispanic Populations

Education for Prevention of Melanoma in Hispanic Populations

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05388851
Enrollment
145
Registered
2022-05-24
Start date
2022-01-12
Completion date
2022-09-13
Last updated
2025-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma

Brief summary

This clinical trial is to develop an educational platform to educate and prevent melanoma in Hispanic populations. Melanoma is cancer arising in the skin. Educational platforms to increase the knowledge and practice of sun smart behaviors (sunscreen use, sun protective clothing use, self-skin examination) may help reduce risk of and incidence of melanoma and improve cancer survival.

Detailed description

PRIMARY OBJECTIVES: I. Develop online education platform to educate the Hispanic community. II. Demonstrate improvement in knowledge and practice of sun smart behaviors. III. Determine if the education platform leads to increase visits to their medical provider and increase diagnosis of skin cancers, particularly melanoma, in our population. OUTLINE: Participants complete an educational training module and complete questionnaire at baseline (before educational training module) and 3 months after completing educational training.

Interventions

OTHEREducational Intervention

Complete educational training module

OTHERQuestionnaire Administration

Complete questionnaire

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Mayo Clinic patients who self-identify as Hispanic or Latino * Age 18 and older * Have an email on file with Mayo Clinic

Exclusion criteria

* All patients who do not meet inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Knowledge score after completing the educational moduleUp to 3 monthsFor quantitative variables, descriptive statistics including number of observations, mean, median, standard deviation, and range will be given for the values. Qualitative variables will be summarized using counts and percentages. Associations between quantitative variables will be conducted using the Pearson linear correlation coefficient, and the Chi-squared or Fisher's exact test for categorical variables.The melanoma knowledge score will be a percent correct, between 0% and 100% (100% is the best score), on a participant questionnaire. The primary outcome is the change in participant melanoma knowledge score before and immediately after completing the melanoma education (the intervention in this study).

Secondary

MeasureTime frameDescription
Knowledge score three months after completing the educational module3 months after completing education moduleFor quantitative variables, descriptive statistics including number of observations, mean, median, standard deviation, and range will be given for the values. Qualitative variables will be summarized using counts and percentages. Associations between quantitative variables will be conducted using the Pearson linear correlation coefficient, and the Chi-squared or Fisher's exact test for categorical variables.The secondary outcome is their melanoma knowledge score at the three-month follow-up.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026